# Sorrento Therapeutics, Inc.

Canonical: https://abierto.us/vendors/sorrento-therapeutics-inc-kwewlhz59fl3

- UEI: KWEWLHZ59FL3
- CAGE: 5SPZ9
- Location: San Diego, CA
- Awards in window: 1 (2 transactions), $0 obligated, February 8, 2024 to April 25, 2025

## Awarding agencies

- National Institutes of Health: 1 awards, $0

## Industries

- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology): $0

## Competition

- Full and Open Competition: 1 awards

## Largest awards

- 75N93023C00024 (definitive contract): $0, National Institutes of Health Niaid. BAA Research Area 004 - "development of in Vitro for Biodefense, Antimicrobial Resistant (Amr) Infections and Emerging Infectious Diseases". https://www.usaspending.gov/award/CONT_AWD_75N93023C00024_7529_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/sorrento-therapeutics-inc-kwewlhz59fl3.